Literature DB >> 12050162

The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway.

Kei Sakamoto1, Shunji Yamaguchi, R Ando, Atsushi Miyawaki, Yuji Kabasawa, Minoru Takagi, Chang Long Li, Bernard Perbal, Ken-ichi Katsube.   

Abstract

We demonstrate a novel interaction of the nephroblastoma overexpressed gene (NOV), a member of the CCN gene family, with the Notch signaling pathway. NOV associates with the epidermal growth factor-like repeats of Notch1 by the CT (C-terminal cysteine knot) domain. The promoters of HES1 and HES5, which are the downstream transducers of Notch signaling, were activated by NOV. Expressions of NOV and Notch1 were concomitant in the presomitic mesoderm and later in the myocytes and chondrocytes, suggesting their synergistic effects in mesenchymal cell differentiation. In C2/4 myogenic cells, elevated expression of NOV led to down-regulation of MyoD and myogenin, resulting in inhibition of myotube formation. These results indicate that NOV-Notch1 association exerts a positive effect on Notch signaling and consequently suppresses myogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050162     DOI: 10.1074/jbc.M203727200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Report on the second international workshop on the CCN family of genes.

Authors:  B Perbal; D R Brigstock; L F Lau
Journal:  Mol Pathol       Date:  2003-04

Review 2.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 3.  Canonical and non-canonical Notch ligands.

Authors:  Brendan D'Souza; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

4.  Isolation of putative FOXO1 genomic elements using an improved in vitro technique to isolate genomic regulatory sequences.

Authors:  Alpa Sidhu; Patrick J Miller; Andrew D Hollenbach
Journal:  Gene       Date:  2010-03-23       Impact factor: 3.688

5.  Overexpression of Notch1 ectodomain in myeloid cells induces vascular malformations through a paracrine pathway.

Authors:  Xiujie Li; Ezequiel Calvo; Marc Cool; Pavel Chrobak; Denis G Kay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

6.  Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts.

Authors:  Norio Motohashi; Akiyoshi Uezumi; Erica Yada; So-ichiro Fukada; Kazuhiro Fukushima; Kazuhiko Imaizumi; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

7.  Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.

Authors:  Marie Monet-Leprêtre; Boris Bardot; Barbara Lemaire; Valérie Domenga; Ophélia Godin; Martin Dichgans; Elisabeth Tournier-Lasserve; Michel Cohen-Tannoudji; Hugues Chabriat; Anne Joutel
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

8.  Thrombospondin 2 potentiates notch3/jagged1 signaling.

Authors:  He Meng; Xiaojie Zhang; Kurt D Hankenson; Michael M Wang
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

9.  WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair.

Authors:  Dorothy M French; Raji J Kaul; Aloma L D'Souza; Craig W Crowley; Min Bao; Gretchen D Frantz; Ellen H Filvaroff; Luc Desnoyers
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 10.  Notch: A multi-functional integrating system of microenvironmental signals.

Authors:  Bryce LaFoya; Jordan A Munroe; Masum M Mia; Michael A Detweiler; Jacob J Crow; Travis Wood; Steven Roth; Bikram Sharma; Allan R Albig
Journal:  Dev Biol       Date:  2016-08-24       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.